The prevalence of metabolic syndrome according to the Iranian Committee of Obesity and ATP III criteria in Babol, North of Iran

Caspian Journal of Internal Medicine

Volumn 3, Issue 2, 2012, Pages 410-416

  Mahjoub, Soleiman ^a   Ahmadi, Mahmoud Haji ^a   Faramarzi, Mahbobeh ^a   Ghorbani, Hiva ^a   Moazezi, Zoleika ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ATP III criteria; Babol; Cardiovascular diseases; Diabetes; Metabolic syndrome; Obesity; Prevalence

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ADULT TREATMENT PANEL III CRITERIA; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IRAN; IRANIAN COMMITTEE OF OBESITY CRITERIA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PREVALENCE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84861955361     PISSN: 20086164     EISSN: 20086172     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mahjoub S, Masrour Roudsari J. Role of oxidative stress in pathogenesis of metabolic syndrome. Caspian J Intern Med 2012; 3: 386-96.
2. Mahjoub S, Haji Ahmadi M, Faramarzi M, et al. How is Lipid Profile and Morbidity Risk in Smokers and Nonsmokers? Caspian J Intern Med 2010; 1: 128-133.
3. Balkau B, Valensi P, Eschwège E, Slama G. A review of the metabolic syndrome. Diabetes Metab 2007; 33: 405-13.
4. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.
5. Mahjoub S, Hasanjani Roshan MR, Gholami M. Evaluation of oxidative stress before and after treatment of patients with acute brucellosis. 12th Iranian Congress of Biochemistry and 4th International Congress of Biochemistry and Molecular Biology. 2011 Sep 6-9; Mashhad, Iran. Elsevier; Clinical Biochemistry 2011; 44: S365.
6. Gholami M, Hasanjani Roshan MR, Mahjoub S, Bijani A. How is total antioxidant status in plasma of patients with brucellosis? Caspian J Intern Med 2012; 3: 363- 7.
7. Mahjoub S, Jalali F, Seyyedi A. Status of Plasma Lipid Peroxidation in Patients with congestive Heart Failure. Euro Prevent Congress; 2009 May 6-9. Stockholm, Sweden. Eur J Cardiovasce Prev Rehabil 2009; 16: S58.
8. Mahjoub S, Tamadoni A, Gorji R. Lipid and Protein Peroxidation in Patients with beta- Thalassemia Major and Intermedia. 3rd International Congress on Biochemistry and Molecular Biology (3rd ICBMB); 2009 Nov 16-19; Tehran, Iran. J Iranian Chem Society, 2009; 6: 40.
9. Mahjoub S, Jalali F, Askari M. Plasma Total Antioxidant Capacity in Patients with Congestive Heart Failure. 16th Congress of Iranian Heart Association in collaboration with American College of Cardiology; 2008 Nov 18-21; Tehran Iran. Iranian Heart J 2008; Suppl 6: S55.
10. Mahjoub S, Tamadoni A, Nikoo M, Moghadamnia AA. Oral supplement of vitamin E and beta carotene reduce lipid & protein peroxidation of erythrocytes in beta-Thalassemia major patients. 9th Iranian Congress of Biochemistry and The Second International Congress of Biochemistry & Molecular Biology; 2007 Oct 29-Nov1; Shiraz, Iran. Arch Iran Med 2007; 10: S19.
11. Mahjoub S, Tamadoni A, Nikoo M. Iron overload and oxidative stress in beta-Thalassemia patients in north of Iran. 11th Asian Pacific Congress of Clinical Biochemistry; 2007 Oct 14-16; Beijing, China. Chinese Med J 2007; 120: 187.
12. Mahjoub S, Tamadoni M, Nikoo M, Moghadamnia AA. The effects of beta carotene and vitamin E on erythrocytes lipid peroxidation in beta-thalassemia. J Res Med Sci 2007; 12: 301-7.
13. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucosed study. Diabetes Res Clin Pract 2003; 61:29-37.
14. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The National Survey of Risk Factors for Noncommunicable Diseases of Iran. Diabetes Care 2009, 32: 1092-7.
15. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15: 539-53.
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
17. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003, 9: 237-52.
18. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: URL: http://www.idf.org/webdata/docs/Metabolic_syndrome_definition.pdf. Accessed, Sep 2, 2005.
19. Azizi F, Khalili D, Aghajani H, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med 2010; 13: 243-4.
20. Fakhrzadeh H, Ebrahim Pour P, Nouri M, et al. Evaluation of prevalence of the metabolic syndrome in inhabitants of Tehran University of Medical Sciences population lab. Iran J Diabet Lipid Disor 2004; 3: 71-80. [In Persian]
21. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular Morbidity and mortality associated with the metabolic syndrome. Diabetes care 2001; 24: 683-9.
22. Villegas R, Perry IJ, Creagh D, Hinchion R, O'Halloran D. Prevalence of the metabolic syndrome in middle-aged men and women. Dibetes care 2003; 26: 3198-9.
23. Sattar N, Gaw A, Scherbakova O, Ford I, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-9.
24. Sarrafzadegan N, Kelishadi R, Baghaei A, et al. Metabolic Metabolic syndrome: an emerging public health problem in Iranian Women: Isfahan Health heart program. Int J cardiol 2008; 131: 90-6.
25. Sharifi F, Mousavinasab SN, Saeini M, Dinmohammadi M. Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res 2009; 2009: 136501.
26. Alexander CM. The coming of age of the metabolic syndrome. Diabetes Care 2003; 26: 3180-1.
27. Malekzadeh R, Mohamadnejad M, Merat Sh, Pourshams A, Etemadi A. Obesity pandemic: an Iranian perspective. Arck Iran Med 2005; 8:1-7.
28. Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovasscular risk in women: A report from the women's Ischemia syndrome evaluation (WISE) study. Ciculation 2004; 109: 706-13.
29. Anand SS, Yi Q, Gerstein H, et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108: 420-5.